IBDEI0ZF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17272,1,4,0)
 ;;=4^V12.40
 ;;^UTILITY(U,$J,358.3,17272,1,5,0)
 ;;=5^HX OF UNSP DISORD NERV SYST
 ;;^UTILITY(U,$J,358.3,17272,2)
 ;;=^295259
 ;;^UTILITY(U,$J,358.3,17273,0)
 ;;=V12.69^^88^1057^2
 ;;^UTILITY(U,$J,358.3,17273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17273,1,4,0)
 ;;=4^V12.69
 ;;^UTILITY(U,$J,358.3,17273,1,5,0)
 ;;=5^HX RESP SYSTEM DIS NEC
 ;;^UTILITY(U,$J,358.3,17273,2)
 ;;=^332856
 ;;^UTILITY(U,$J,358.3,17274,0)
 ;;=V15.29^^88^1057^3
 ;;^UTILITY(U,$J,358.3,17274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17274,1,4,0)
 ;;=4^V15.29
 ;;^UTILITY(U,$J,358.3,17274,1,5,0)
 ;;=5^HX SURGERY TO ORGANS NEC
 ;;^UTILITY(U,$J,358.3,17274,2)
 ;;=^336785
 ;;^UTILITY(U,$J,358.3,17275,0)
 ;;=V12.3^^88^1057^4
 ;;^UTILITY(U,$J,358.3,17275,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17275,1,4,0)
 ;;=4^V12.3
 ;;^UTILITY(U,$J,358.3,17275,1,5,0)
 ;;=5^HX-BLOOD DISEASES
 ;;^UTILITY(U,$J,358.3,17275,2)
 ;;=^295258
 ;;^UTILITY(U,$J,358.3,17276,0)
 ;;=V12.72^^88^1057^5
 ;;^UTILITY(U,$J,358.3,17276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17276,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,17276,1,5,0)
 ;;=5^HX-COLONIC POLYPS
 ;;^UTILITY(U,$J,358.3,17276,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,17277,0)
 ;;=V12.29^^88^1057^6
 ;;^UTILITY(U,$J,358.3,17277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17277,1,4,0)
 ;;=4^V12.29
 ;;^UTILITY(U,$J,358.3,17277,1,5,0)
 ;;=5^HX-ENDOCR/META/IMMUN DIS
 ;;^UTILITY(U,$J,358.3,17277,2)
 ;;=^340614
 ;;^UTILITY(U,$J,358.3,17278,0)
 ;;=V12.03^^88^1057^7
 ;;^UTILITY(U,$J,358.3,17278,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17278,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,17278,1,5,0)
 ;;=5^HX-MALARIA
 ;;^UTILITY(U,$J,358.3,17278,2)
 ;;=^303395
 ;;^UTILITY(U,$J,358.3,17279,0)
 ;;=V12.1^^88^1057^8
 ;;^UTILITY(U,$J,358.3,17279,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17279,1,4,0)
 ;;=4^V12.1
 ;;^UTILITY(U,$J,358.3,17279,1,5,0)
 ;;=5^HX-NUTRITION DEFICIENCY
 ;;^UTILITY(U,$J,358.3,17279,2)
 ;;=^295256
 ;;^UTILITY(U,$J,358.3,17280,0)
 ;;=V12.79^^88^1057^9
 ;;^UTILITY(U,$J,358.3,17280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17280,1,4,0)
 ;;=4^V12.79
 ;;^UTILITY(U,$J,358.3,17280,1,5,0)
 ;;=5^HX-OTH SPEC DIGEST DIS
 ;;^UTILITY(U,$J,358.3,17280,2)
 ;;=^303402
 ;;^UTILITY(U,$J,358.3,17281,0)
 ;;=V12.71^^88^1057^10
 ;;^UTILITY(U,$J,358.3,17281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17281,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,17281,1,5,0)
 ;;=5^HX-PEPTIC ULCER DISEASE
 ;;^UTILITY(U,$J,358.3,17281,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,17282,0)
 ;;=V12.02^^88^1057^11
 ;;^UTILITY(U,$J,358.3,17282,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17282,1,4,0)
 ;;=4^V12.02
 ;;^UTILITY(U,$J,358.3,17282,1,5,0)
 ;;=5^HX-POLIO
 ;;^UTILITY(U,$J,358.3,17282,2)
 ;;=^303394
 ;;^UTILITY(U,$J,358.3,17283,0)
 ;;=V12.09^^88^1057^12
 ;;^UTILITY(U,$J,358.3,17283,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17283,1,4,0)
 ;;=4^V12.09
 ;;^UTILITY(U,$J,358.3,17283,1,5,0)
 ;;=5^HX-SPEC INF & PARA DIS
 ;;^UTILITY(U,$J,358.3,17283,2)
 ;;=^303396
 ;;^UTILITY(U,$J,358.3,17284,0)
 ;;=V12.01^^88^1057^13
 ;;^UTILITY(U,$J,358.3,17284,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17284,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,17284,1,5,0)
 ;;=5^HX-TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,17284,2)
 ;;=^303393
 ;;^UTILITY(U,$J,358.3,17285,0)
 ;;=V12.70^^88^1057^14
 ;;^UTILITY(U,$J,358.3,17285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17285,1,4,0)
 ;;=4^V12.70
 ;;^UTILITY(U,$J,358.3,17285,1,5,0)
 ;;=5^HX-UNSP DIGEST DISEASE
 ;;^UTILITY(U,$J,358.3,17285,2)
 ;;=^295262
 ;;^UTILITY(U,$J,358.3,17286,0)
 ;;=V12.00^^88^1057^15
 ;;
 ;;$END ROU IBDEI0ZF
